NIH-funded research NIH-funded research

Real-time sensor network to track inflammatory cytokines in chronic illness

Official title: Integrating Real-Time Multi-System Cytokine Signaling in Chronic Disease

Funded at State University New York Stony Brook · NIH-11394190 · Data updated 2026-11-12

This project develops tiny injectable sensors that continuously track inflammatory proteins to better understand and eventually help manage chronic conditions like autoimmune disease, cancer, and heart disease.

More Chronic Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startAugust 1, 2021
Project endMay 31, 2027
Funding year2025
Award (this year)$365,190
NIH project number7R35GM142833-06
Project IDNIH-11394190 on NIH RePORTER

Who could benefit from this research

Could help

Future human testing would likely focus on people with chronic inflammatory conditions such as autoimmune diseases, inflammation-driven cancers, or chronic cardiovascular inflammation.

Less likely to help

People without inflammation-driven conditions or those seeking immediate therapeutic effects rather than monitoring are unlikely to gain direct benefit from this work.

What this research studies

Researchers plan to build fluorescent carbon nanosensors that can detect several inflammatory cytokines at once and embed them in a soft, injectable gel that stays under the skin. The sensors are designed to report rapid changes in cytokine levels that standard blood tests miss and to function for months without moving. Work will start with validation and tuning in mice, including tests that inject known cytokines and disease models to confirm sensitivity and specificity. The goal is a minimally invasive network that maps how inflammatory signals change over time in chronic illnesses and could later be adapted for human use.

Why it matters

Potential benefit: If successful, this technology could let patients and clinicians monitor inflammatory activity continuously and time treatments or detect flares earlier.

How similar studies have gone: Related nanosensor work exists, but multiplexed, long-term in vivo cytokine monitoring is largely novel and has not been proven in humans.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Williams, Ryan Martin — State University New York Stony Brook
  • Study coordinator: Williams, Ryan Martin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.